Managed Account Advisors’s GSK GSK Stock Holding History

Managed Account Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$95.3M	Sell	1,830,072 -594,798	-25%	-$33.5M	0.08%	272
2015 Q1	$140M	Buy	2,424,870 +382,142	+19%	+$21.9M	0.12%	197
2014 Q4	$109M	Sell	2,042,728 -1,453,165	-42%	-$81.3M	0.11%	222
2014 Q3	$201M	Buy	3,495,893 +3,427	+0.1%	+$210K	0.22%	116
2014 Q2	$233M	Buy	3,492,466 +1,648,980	+89%	+$112M	0.28%	87
2014 Q1	$123M	Sell	1,843,486 -102,420	-5%	-$6.92M	0.16%	153
2013 Q4	$130M	Buy	1,945,906 +8,826	+0.5%	+$572K	0.17%	137
2013 Q3	$121M	Sell	1,937,080 -73,553	-4%	-$4.73M	0.18%	137
2013 Q2	$126M	Buy	+2,010,633	New	+$128M	0.19%	128

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Managed Account Advisors's GSK Position: Q2 2015 in Review

Managed Account Advisors reduced its GSK (GSK) stake by 25% in Q2 2015, selling an estimated $33.5M and leaving 1,830,072 shares worth $95.3M. The position accounts for 0.08% of the portfolio, ranked #272.

Managed Account Advisors first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $233M in Q2 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Managed Account Advisors held 1,830,072 shares of GSK worth $95.3M as of Q2 2015.
Managed Account Advisors sold 594,798 GSK shares in Q2 2015, an estimated $33.5M.
GSK made up 0.08% of Managed Account Advisors's portfolio in Q2 2015, its #272 holding.
Managed Account Advisors first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's GSK position peaked at $233M in Q2 2014.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.